Cirrhosis

Last reviewed: 3 Jun 2022
Last updated: 15 Mar 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • abdominal distension
  • jaundice and pruritus
  • blood in vomit (haematemesis) and black stool (melaena)
  • hand and nail features (e.g., leukonychia, palmar erythema, spider naevi)
  • facial features (e.g., telangiectasia, spider naevi, jaundiced sclera)
  • abdominal features (e.g., collateral circulation, hepatosplenomegaly, distension)
  • altered mental status
More key diagnostic factors

Other diagnostic factors

  • constitutional symptoms
  • lower extremity swelling
  • hepatic fetor
  • muscle wasting
  • peripheral oedema
  • recurrent infections
  • decreased libido
  • chest wall features (e.g., gynaecomastia)
  • dyspnoea
  • chest pain
  • syncope
Other diagnostic factors

Risk factors

  • alcohol misuse
  • intravenous drug use
  • unprotected intercourse
  • obesity
  • country of birth
  • blood transfusion
  • tattooing
More risk factors

Diagnostic investigations

1st investigations to order

  • liver function tests
  • gamma-glutamyl transferase (GGT)
  • serum albumin
  • serum sodium
  • prothrombin time
  • platelet count
  • antibodies to hepatitis C virus
  • hepatitis B surface antigen
More 1st investigations to order

Investigations to consider

  • total iron, total iron binding capacity (TIBC), transferrin saturation, and ferritin
  • antinuclear antibody
  • antismooth muscle antibody
  • antimitochondrial antibody
  • serum ceruloplasmin
  • plasma alpha-1 antitrypsin
  • serum protein electrophoresis
  • abdominal ultrasound
  • abdominal CT
  • abdominal MRI
  • upper gastrointestinal endoscopy
  • liver biopsy
  • non-invasive tests of liver elasticity
More investigations to consider

Treatment algorithm

ONGOING

all patients

Contributors

Authors

Grace E. Dolman, PhD MA (Cantab) MRCP

Clinical Research Fellow

Barts Liver Centre

Barts and the London School of Medicine and Dentistry

London

UK

Disclosures

GED declares that she has no competing interests.

Patrick T. F. Kennedy, MB BCh BAO BMedSci FRCP MD

Reader and Honorary Consultant in Hepatology

Barts Liver Centre

Barts and the London School of Medicine and Dentistry

London

UK

Disclosures

PTFK acts as an advisor for Gilead Sciences, Janssen, and Immunocore. PTFK has received grant funding from Gilead Sciences. These roles are unrelated to the current article.

Acknowledgements

Dr Grace E. Dolman and Dr Patrick T. F. Kennedy would like to gratefully acknowledge Dr Keith D. Lindor and Dr Flavia Mendes, previous contributors to this topic.

Disclosures

KDL is an unpaid advisor for Intercept Pharmaceuticals and Shire Pharmaceuticals. FM declares that she has no competing interests.

Peer reviewers

Nancy Reau, MD

Assistant Professor of Medicine

University of Chicago

Center for Liver Disease

Chicago

IL

Disclosures

NR declares that she has no competing interests.

Cynthia Levy, MD

Clinical Assistant Professor

Division of Gastroenterology Hepatology and Nutrition

University of Florida

Gainesville

FL

Disclosures

CL declares that she has no competing interests.

James Neuberger, DM, FRCP, Hon

Consultant Physician

Hon Professor in Medicine

Associate Medical Director NHSBT

Queen Elizabeth Hospital

Birmingham

UK

Disclosures

JN declares that he has no competing interests.

  • Cirrhosis images
  • Differentials

    • Budd-Chiari syndrome
    • Portal vein thrombosis
    • Splenic vein thrombosis
    More Differentials
  • Guidelines

    • Acute-on-chronic liver failure clinical guidelines
    • Diagnosis, evaluation, and management of ascites and hepatorenal syndromes
    More Guidelines
  • Patient leaflets

    Cirrhosis: what is it?

    Cirrhosis: what treatments work?

    More Patient leaflets
  • Videos

    Ascitic drainage animated demonstration

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer